These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3082075)

  • 1. Serum ALT levels in patients with primary hypogammaglobulinaemia receiving replacement therapy with intravenous immunoglobulin or fresh frozen plasma.
    Leen CL; Yap PL; Neill G; McClelland DB; Westwood A
    Vox Sang; 1986; 50(1):26-32. PubMed ID: 3082075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance of Scottish National Blood Transfusion Service intravenous immunoglobulin in patients with primary hypogammaglobulinaemia: report of 1235 infusions.
    Leen CL; Yap PL; Williams PE; McClelland DB
    Scott Med J; 1988 Aug; 33(4):303-6. PubMed ID: 3187500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of the safety of three intravenous immunoglobulin preparations in patients with primary hypogammaglobulinaemia.
    Yap PL; McClelland DB
    J Infect; 1986 Jan; 12(1):5-10. PubMed ID: 3082994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increase of serum immunoglobulin level into the normal range in primary hypogammaglobulinaemia by dosage individualization of intravenous immunoglobulin.
    Leen CL; Yap PL; McClelland DB
    Vox Sang; 1986; 51(4):278-86. PubMed ID: 3798863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmission of non-A, non-B hepatitis by pH4-treated intravenous immunoglobulin.
    Williams PE; Yap PL; Gillon J; Crawford RJ; Urbaniak SJ; Galea G
    Vox Sang; 1989; 57(1):15-8. PubMed ID: 2508325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of treatment of children with hypogammaglobulinemia: comparison of fresh plasma and intravenous immunoglobulin preparation.
    Bernatowska E; Weremowicz R; Janowicz W; Madaliński K
    Arch Immunol Ther Exp (Warsz); 1986; 34(4):377-84. PubMed ID: 3099724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973-93.
    Skull S; Kemp A
    Arch Dis Child; 1996 Jun; 74(6):527-30. PubMed ID: 8758130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgG replacement therapy for primary hypogammaglobulinaemia during pregnancy: report of 9 pregnancies in 4 patients.
    Williams PE; Leen CL; Heppleston AD; Yap PL
    Blut; 1990 Mar; 60(3):198-201. PubMed ID: 2317569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute unidentified hepatitis in a hypogammaglobulinaemic patient on intravenous gammaglobulin successfully treated with interferon.
    Lockner D; Bratt G; Lindborg A; Törnebohm E
    Acta Med Scand; 1987; 221(4):413-5. PubMed ID: 3111178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and kinetics of a solvent-detergent-treated intravenous immunoglobulin preparation in hypogammaglobulinaemia patients.
    Ebeling F; Baer M; Hormila P; Järventie G; Koistinen P; Kätkä K; Oksanen K; Perkkiö M; Ruutu T; Soppi E
    Vox Sang; 1995; 69(2):91-4. PubMed ID: 8585206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease.
    Roifman CM; Levison H; Gelfand EW
    Lancet; 1987 May; 1(8541):1075-7. PubMed ID: 2883406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of intravenous gamma globulin in multiple myeloma.
    Gordon DS; Hearn EB; Spira TJ; Reimer CB; Phillips DJ; Schable C
    Am J Med; 1984 Mar; 76(3A):111-6. PubMed ID: 6424442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penetration of administered IgG into the maxillary sinus and long-term clinical effects of intravenous immunoglobulin replacement therapy on sinusitis in primary hypogammaglobulinaemia.
    Williams P; White A; Wilson JA; Yap PL
    Acta Otolaryngol; 1991; 111(3):550-5. PubMed ID: 1887782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged interval high-dose intravenous immunoglobulin in patients with primary immunodeficiency states.
    Montanaro A; Pirofsky B
    Am J Med; 1984 Mar; 76(3A):67-72. PubMed ID: 6424459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Build-up maintenance of IgG serum concentrations with intravenous immunoglobulin in patients with primary humoral immunodeficiency.
    Morell A; Schnoz M; Barandun S
    Vox Sang; 1982; 43(4):212-9. PubMed ID: 7135889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases.
    Ochs HD; Fischer SH; Wedgwood RJ; Wara DW; Cowan MJ; Ammann AJ; Saxon A; Budinger MD; Allred RU; Rousell RH
    Am J Med; 1984 Mar; 76(3A):78-82. PubMed ID: 6424461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose of intravenous IgG in primary hypogammaglobulinaemia.
    Williams PE; Yap PL; McClelland DB
    Lancet; 1987 Jun; 1(8547):1435-6. PubMed ID: 2884526
    [No Abstract]   [Full Text] [Related]  

  • 18. A prospective controlled crossover trial of a new heat-treated intravenous immunoglobulin.
    Zuhrie SR; Webster AD; Davies R; Fay AC; Wallington TB
    Clin Exp Immunol; 1995 Jan; 99(1):10-5. PubMed ID: 7813100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-A non-B hepatitis and the safety of intravenous immune globulin, pH 4.2: a retrospective survey. Preliminary communication.
    Rousell RH; Good RA; Pirofsky B; Schiff RI
    Vox Sang; 1988; 54(1):6-13. PubMed ID: 3126601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The viral safety of intravenous immunoglobulin.
    Cuthbertson B; Perry RJ; Foster PR; Reid KG; Crawford RJ; Yap PL
    J Infect; 1987 Sep; 15(2):125-33. PubMed ID: 3117893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.